Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Dispensing

Pharmacies' dispensing increases by up to a third as a result of COVID-19, survey finds

All 1,410 pharmacies that took part in a National Pharmacy Association survey reported a significant increase in workload.

Open access article

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.

To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus

Pharmacist dispensing medicines in a pharmacy

Source: Alamy Stock Photo

Some of the community pharmacies surveyed reported a 300% increase in home deliveries

Pharmacies dispensed between a quarter and a third more prescriptions in March 2020, compared with the previous month, according to a survey by the National Pharmacy Association (NPA).

The survey of 1,410 pharmacies also revealed that the number of home deliveries provided by pharmacies more than doubled in that time, with some reporting a 300% increase.

Meanwhile, the number of phone calls to pharmacies was also found to have tripled over the month, with all pharmacies reporting a significant increase in working hours that often required them to hire locum staff to manage the workload.

The NPA hosted the survey, between 30 March and 3 April 2020, to help the Pharmaceutical Services Negotiating Committee (PSNC) calculate the extra costs facing community pharmacies during the COVID-19 pandemic, following the government’s pledge to give the sector advance funding of £300m.

The PSNC said on 31 March 2020 that the advance, which pharmacies will receive over April and May 2020, “will need to be reconciled at a later date”, adding that negotiations for more money would continue as the £300m “is not sufficient to cover contractors’ rising costs”.

At the time of the announcement, other pharmacy bodies said the initial installment of £200m in April would “only just cover half of the estimated uplift in prescription items”. 

In a statement to The Pharmaceutical Journal, the NPA said that while it could not estimate the total cost that pharmacies will incur as a result of the pandemic, pharmacies had seen the number of prescriptions dispensed increase by “approximately 25–35% from February to March [2020]”. 

Andrew Lane, acting chair of the NPA, said that pharmacies are facing “extra costs relating to medicines, staffing, personal protection and many other financial outlays that cannot be avoided”.

“They have every right to expect the costs to be repaid by government and that is indeed what has been promised,” he said.

“It’s a matter of service continuity in the short term, and business survival in the long term, for a sector which has stepped up in this national crisis to save lives.”

Local pharmaceutical committees have previously told The Pharmaceutical Journal that demand for prescriptions is similar to “Christmas and Easter combined”, with extra funding urgently needed to avoid permanent pharmacy closures.

In an effort ease the demand, the government announced in March 2020 that pharmacies would be able to use NHS volunteers to meet the increased need to for home deliveries.

However, some pharmacies have since said they would not use the volunteers, instead using their own DBS-checked delivery drivers, owing to concerns around extra workload and risk.

On 14 April 2020, NHS England announced an essential service that means pharmacies must help patients who are shielding to receive their prescriptions, either through family or friends, the NHS volunteer service or by delivering it as part of a pharmacy-run advanced delivery service.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207917

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.